CLIENT NEWS
- InflaRx Announces Top-Line SHINE Phase IIb Results for IFX-1 in Hidradenitis Suppurativa05 June 2019
- Heidelberg Pharma Receives Milestone Payment from Partner Telix05 June 2019
- Verona Pharma Initiates Phase 2 Clinical Trial with Metered Dose Inhaler Formulation of Ensifentrine for Maintenance Treatment of COPD05 June 2019
- Ergomed Strengthens Executive Team with Appointment of Richard Barfield, Formerly of Chiltern International, as Chief Financial Officer04 June 2019
- Abivax Receives First Clinical Trial Authorization for ABX464 Phase 2a Study in Patients with Rheumatoid Arthritis04 June 2019
- AYOXXA launches next generation LUNARISTM Reader to facilitate translational research in academic and industrial laboratories03 June 2019
- Rentschler Fill Solutions appoints Dr. Friedrich Sernetz as Chief Executive Officer03 June 2019
- Motif Bio plc: Result of Annual General Meeting31 May 2019
- Molecular Health signs up HudsonAlpha Institute for Biotechnology as new U.S. customer for MH Guide31 May 2019
- Biom’up SA: Industry Veteran Dr. Jan Ohrstrom takes on Executive Leadership of Biom’up30 May 2019